PouchDaily topic
Nicotine-pouch reporting, research and analysis connected to FDA.
regulation
FDA greenlights 11 ZYN Ultra pouches — including its first 11mgOn 21 August 2026 the FDA issued Marketing Granted Orders for 11 ZYN Ultra nicotine pouches from Swedish Match USA — ten 9mg flavours and a new 11mg Smooth. The authorizations push the total of FDA-authorized nicotine pouch products to 43, with 23 cleared through the agency’s nicotine pouch pilot program. The American Lung Association attacked the move, citing youth appeal.
regulation
FDA lets ZYN claim it’s safer than cigarettes — doctors push backThe FDA issued Modified Risk Tobacco Product orders for 20 ZYN nicotine pouch products on 30 June 2026 — the first time any nicotine pouch has been cleared to advertise reduced disease risk versus cigarettes. The authorised claim covers mouth cancer, heart disease, lung cancer, stroke, emphysema and chronic bronchitis. Public health experts say the labelling could normalise nicotine for new users — and point to 460,000 youth pouch users as evidence the category is already reaching kids.
regulation
Court clips FDA’s tobacco authority — nicotine pouch rules could be nextA federal appeals court ruled the FDA exceeded its authority by requiring 11 graphic cigarette warnings — Congress only authorized nine. The same legal theory — that the agency went beyond what Congress allowed — is being used to challenge the FDA’s nicotine pouch enforcement guidance in a separate lawsuit.
regulation
Trump's FDA pick will decide the fate of unauthorized nicotine pouchesTrump has tapped White House health aide Dr. Heidi Overton to run the FDA. She'd inherit a controversial policy that lets some unauthorized nicotine pouches stay on sale while their applications sit pending — and she hasn't said whether she'd keep it.
regulation
Health groups sue the FDA as agency greenlights 30 nicotine pouch productsThe FDA has authorized 30 nicotine pouch products in 2026 — including 20 ZYN pouches with reduced-risk claims and four new flavored on! pouches. Public health groups, pediatricians and parents responded by suing the agency, arguing its enforcement policy lets products reach the market without legally required scientific review. The American Heart Association says the program was "never adequately explained to the public."
product
A child-safe cap that retrofits any nicotine pouch canChemular's Safeguard Mark I adds child-resistant packaging to existing nicotine pouch cans without a redesign — responding to FDA pressure after poison-control data showed 72% of pouch exposures involved children under 5. All 20 FDA-authorized pouch products already use CRC packaging.
market
On! Volume Hits 47M Cans—But Share Drops to 13.9% as ZYN and Velo Outpace Altria's GrowthAltria's On! shipped 47.2 million cans in Q2 2026, up 17% sequentially, but its U.S. retail share fell to 13.9% in H1 (from 16.8% a year ago) as the $13.4B pouch category grows faster than On! can capture it.
science
FDA Drops PATH Wave 8 Data — Nicotine Pouch-usage in focus!The FDA just released Wave 8 of the PATH Study, the federal government's most comprehensive look at nicotine pouch usage in America. Here's what the data covers.
regulation
FDA Authorizes Four NEW Nicotine Pouches — First Signal the Category Can Market as Lower-RiskThe FDA just authorized four new on! nicotine pouch products, explicitly citing lower levels of harmful constituents compared to traditional oral tobacco. It's the first authorization of its kind — and it opens the door for pouches to claim harm reduction.